Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-03-04 @ 8:46 PM
Study NCT ID:
NCT02813694
Status:
COMPLETED
Last Update Posted:
2019-10-23
First Post:
2016-06-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia
Sponsor:
Nabriva Therapeutics AG
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NAB-BC-3781-3102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None